טוען...
The FDA Guidance on therapeutic cancer vaccines: the need for revision to include preventive cancer vaccines or for a new guidance dedicated to them
Cancer vaccines based on antigens derived from self molecules rather than pathogens, have been under basic and clinical investigations for many years. Up until very recently they had been tested primarily in the setting of metastatic disease with the goal to engage the immune system in slowing down...
שמור ב:
| הוצא לאור ב: | Cancer Prev Res (Phila) |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4633304/ https://ncbi.nlm.nih.gov/pubmed/26353948 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-15-0234 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|